The National Organization For Rare Disorders Inc.

Norwell, MA Doing business as Nord

UEI
PCPAHHLS8VB6
CAGE
062L2
Primary NAICS
813319 Other Social Advocacy Organizations
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
120 Longwater Dr #105, Norwell, MA 02061, USA
Founded
1983
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health & Wellness
SIC code
83 Social Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Disease natural history database development U24FD005664 Food and Drug Administration $250,000

Grant subawards

Prime recipient Prime award Amount Awarded
The Critical Path Institute The National Organization for Rare Disorders (NORD) and Critical Path Institute (C-Path) are uniquely poised to successfully develop and deliver upon the Rare… U18FD005320 $1,085,853
The Critical Path Institute The National Organization for Rare Disorders (NORD) and Critical Path Institute (C-Path) are uniquely poised to successfully develop and deliver upon the Rare… U18FD005320 $1,255,087
Northwestern University Northwestern University Clinical Outcome Assessment Team (NUCOAT) UH3FD006794 $68,445

Similar vendors

About the company

The National Organization For Rare Disorders Inc., doing business as Nord, is a non-profit organization providing advocacy, research support, educational services, and patient assistance programs on behalf of the rare disease community.

Nord has received one prime federal contract award from the Department of Health and Human Services Food and Drug Administration, a $1.46 million definitive cost plus fixed fee contract to support a systems-based approach to patient-focused research and product development related to rare diseases. This contract, awarded in September 2019, runs through June 2024.

Nord has received multiple federal grant subawards to provide various goods and services in support of rare disease research and drug development initiatives. These subawards were provided by prime grantees including The Critical Path Institute and Northwestern University. Nord's subaward activities have included co-hosting meetings and developing outreach plans, contributing to data architecture and acquisition efforts, developing educational content and engagement plans for stakeholders, and supporting governance of rare disease research programs. Through these subawards, Nord lends its expertise and channels within the rare disease community.

Quick answers

Is The National Organization For Rare Disorders Inc. registered in SAM.gov?

Yes. The National Organization For Rare Disorders Inc.'s SAM.gov registration is active through October 12, 2027.

What is The National Organization For Rare Disorders Inc.'s most recent federal award?

The National Organization For Rare Disorders Inc.'s most recent federal contract award is Broad agency announcement: fdavaa-19-00123-A3 " a systems-based approach to patient-focused research and product… (75F40119C10091), from Food and Drug Administration, on September 7, 2019.

On GovTribe

See The National Organization For Rare Disorders Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors